Biogen Inc. (NASDAQ: BIIB) announced it has entered into a definitive agreement to acquire Massachusetts-based Alcyone Therapeutics for an upfront ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE